Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2619-2627

  Cai, G ^a   Radzanowski, T ^a   Villegas, E N ^a   Kastelein, R ^a   Hunter, C A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 2; STAT4 PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; T LYMPHOCYTE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0034283962     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2619     Document Type: Article

References (62)

1. Interferon-γ: The major mediator of resistance against Toxoplasma gondii
2. Importance of endogenous IFN-γ for the prevention of toxoptasmic encephalitis in mice
3. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii
4. Interleukin-12 enhances mufine survival against acute toxoplasmosis
5. Toxoplasma gondii: Evidence for interleukin-12-dependent and -independent pathways of interferon-γ production induced by an attenuated parasite strain
6. + T cell response by IFN-γ in IL-12-deficient mice during Toxoplasma gondii infection
7. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
8. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
9. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
10. IL-12-deficient mice are defective in IFN γ production and type I cytokine response
11. Regulation oft helper cell differentiation by STAT molecules
12. A signal transducer and activator of transcription (Stat)4-independent pathway for the development of T helper type 1 cells
13. IL-12 is not required for induction of type 1 cytokine responses in viral infections
14. Alloantigen-reactive Th1 development in IL-12-deficient mice
15. IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production
16. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation
17. Activation of STAT4 by IL-I2 and IFN-α: Evidence for the involvement of ligand-induced tyrosine and serine phosphorylation
18. IL-1α and TNF-α are required for IL-I2-induced development of Th1 cells producing high levels of IFN-γ in BALB/c but not C57BL/6 mice
19. IL-Iβ is required for IL-12 to induce production of IFN-γ by NK cells, a role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens
20. Production of γ interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: Regulation by interleukin-10, interleukin-12, and tumor necrosis factor α
21. B7 and interleukin 12 cooperate for proliferation and interferon γ production by mouse T helper clones that are unresponsive to B7 costimulation
22. Mechanisms of IFN-γ induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2
23. In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii
24. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii
25. Cloning of a new cytokine that induces IFN-γ production by T cells
26. A newly defined interleukin-1?
27. Interleukin-18: A novel cytokine that augments both innate and acquired immunity
28. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing cells
29. + T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming
30. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB
31. Defective NK cell activity and Th1 response in IL-18-deficient mice
32. Defective interleukin (IL)-18-medialed natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice
33. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice
34. Generation of IL-18 receptor-deficient mice: Evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor
35. Similar frequencies and kinetics of cytokine producing cells in murine peripheral blood and spleen
36. IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-γ when combined with IL-18
37. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection
38. Roles of gamma interferon and other cytokines in suppression of the spleen ceil proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis
39. Comparison of the effects of interleukin-1α, interleukin-1β and interferon-γ-inducing factor on the production of interferon-γ by natural killer
40. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
41. Studies on the role of interleukin-12 in acute murine toxoplasmosis
42. + T cells
43. Mice lacking IL-12 develop polarized Th1 cells during viral infection
44. + T lymphocytes in IFN-γ production and protective immunity induced by an attenuated Toxoplasma gondii vaccine
45. + lymphocytes is required to reactivate chronic infection with Toxoplasma gondii
46. Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii
47. Schistosoma mansoni egg-induced early IL-4 production is dependent upon IL-5 and eosinophils
48. Molecular and cellular biology of mast cells and basophils
49. IL-4 mRNA transcription is induced in mouse bone marrow-derived mast cells through an MHC class II-dependent signaling pathway
50. STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis
51. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-γ production
52. - T cell subsets to express IL-18 receptor and produce IFN-γ in response to IL-18
53. + T cells by costimulation with B7-2 molecules
54. IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor
55. The developmental relationship between NK cells and T cells
56. The NF-κB family member Re1B is required for innate and adaptive immunity to Toxoplasma gondii
57. Requirement for Tec kinases Rlk and ltk in T cell receptor signaling and immunity
58. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions
59. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin-12 p40 induction
60. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
61. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
62. Toxoplasmic encephalitis in A1DS